Himachal High Court Ruling Challenges Central Drug Inspections in India
Legal Roadblock? Why Himachal High Court Judgment May Complicate Centre's Crackdown On Bad Drugs
Image: News 18
The Himachal Pradesh High Court's recent ruling questions the legal authority of the Central Drugs Standard Control Organisation (CDSCO) to conduct inspections and prosecutions under the Drugs and Cosmetics Act. This decision could complicate the Centre's efforts to enforce drug quality standards amid ongoing scrutiny of India's pharmaceutical industry.
- 01The Himachal Pradesh High Court ruled that CDSCO inspectors may lack the legal authority to enforce drug manufacturing regulations under the Drugs and Cosmetics Act.
- 02The case involved Salus Pharmaceuticals, where a drug inspector's actions led to a prosecution based on a drug sample that failed quality testing.
- 03The court emphasized that powers related to drug manufacturing primarily reside with state governments and their appointed inspectors.
- 04Delays in testing drug samples were highlighted, with the court noting that such delays undermine the prosecution's case.
- 05The ruling may set a precedent for pharmaceutical companies to challenge CDSCO inspections and their legal basis.
Advertisement
In-Article Ad
The Himachal Pradesh High Court has raised significant legal questions regarding the enforcement powers of the Central Drugs Standard Control Organisation (CDSCO) in its recent ruling on drug inspections. The case, involving Salus Pharmaceuticals, highlighted that CDSCO inspectors may not have the authority to conduct inspections and prosecutions under the Drugs and Cosmetics Act, particularly concerning drug manufacturing, which the court stated is primarily governed by state authorities. The judgment came after a CDSCO inspector collected a drug sample that was later deemed substandard, leading to prosecution. The court found that delays in testing the sample, which exceeded the mandated 60-day period, weakened the prosecution's case. Furthermore, it ruled that company partners could not be automatically prosecuted without clear evidence of their involvement in daily operations. This ruling could have national implications, potentially allowing pharmaceutical companies to contest the legality of CDSCO inspections and complicating the Centre's efforts to improve drug quality monitoring across India.
Advertisement
In-Article Ad
The ruling may hinder the enforcement of drug quality regulations in Himachal Pradesh and potentially across India.
Advertisement
In-Article Ad
Reader Poll
What do you think about the Himachal High Court's ruling on drug inspections?
Connecting to poll...
More about Central Drugs Standard Control Organisation
Read the original article
Visit the source for the complete story.